SMG
WST icon

Spectrum Management Group’s West Pharmaceutical WST Stock Holding History

Spectrum Management Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-10
Closed -$1K – 265
2017
Q4 		$1K Hold
10
– – ﹤0.01% 247
2017
Q3 		$1K Buy
+10
New +$905 ﹤0.01% 354

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Spectrum Management Group's WST Position: Q1 2018 in Review

Spectrum Management Group sold out of West Pharmaceutical (WST) in Q1 2018, closing a stake of 10 shares — an estimated $1K sold.

Spectrum Management Group first reported a position in WST in Q3 2017 and held it in 2 quarters. The position peaked at $1K in Q4 2017. 323 funds tracked by Wall St. Rank hold WST as of Q1 2018.

  • Spectrum Management Group reported no remaining West Pharmaceutical position as of Q1 2018 after selling out during the quarter.
  • Spectrum Management Group sold 10 West Pharmaceutical shares in Q1 2018, an estimated $1K.
  • Spectrum Management Group first reported a position in West Pharmaceutical in Q3 2017 and held it in 2 quarters.
  • Spectrum Management Group's West Pharmaceutical position peaked at $1K in Q4 2017.
  • 323 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2018.

Based on Spectrum Management Group's 13F filing for Q1 2018, filed 7 May 2018.